Skip to main content
Overview
News
Events & Presentations
Stock Information
Financials
Governance
Resources
About
Leadership
Management Team
Board of Directors
Partners
Research Partners
Strategic Investors
Careers
Open Positions
Science
Redefining Disease
Precision Medicine
Genetically-Defined AMD
Expanded Access
Understanding Ocular Disease
CLARITY Studies
Therapeutic Modalities
Therapeutic Approach
Recombinant Proteins
Gene Therapy
Monoclonal Antibodies
Pipeline
Programs
Complement Factor H
Investors & Media
Contact
Site Search
Search query
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Whistleblower Hotline
Resources
Investor FAQs
Investor Email Alerts
About
Toggle Submenu
Leadership
Management Team
Board of Directors
Partners
Research Partners
Strategic Investors
Scientific Advisors
Founders
Advisory Board
Careers
Open Positions
Science
Toggle Submenu
Redefining Disease
Precision Medicine
Genetically-Defined AMD
Expanded Access
Understanding Ocular Disease
CLARITY Studies
Therapeutic Modalities
Therapeutic Approach
Recombinant Proteins
Gene Therapy
Monoclonal Antibodies
Pipeline
Toggle Submenu
Programs
Complement Factor H
Investors & Media
Toggle Submenu
Contact
Search query
Governance Documents
Overview
News
Events & Presentations
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Whistleblower Hotline
Resources
Investor FAQs
Investor Email Alerts
Download item year list
Download
Description
Audit Committee Charter
(opens in new window)
116 KB
Compensation Committee Charter
(opens in new window)
139 KB
Nominating and Corporate Governance Committee Charter
(opens in new window)
95 KB
Code of Business Conduct and Ethics
(opens in new window)
198 KB
Corporate Governance Guidelines
(opens in new window)
257 KB